Ahmed Mutanabbi Abdula

Dr. Ahmed Mutanabbi Abdula

Chemistry, Mustansiriyah University, Baghdad, Baghdād, Iraq
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Journal of Saudi Chemical Society
Verified
Journal Article
Open access
ITIvan Tom
Ivan Tom
AAAli H.R. Al-Daraji
Ali H.R. Al-Daraji
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
MAMohammed F. Al-Marjani
Mohammed F. Al-Marjani
A novel series of 2-[5-(4-substituted phenyl)furan-2-yl]-4,5-diphenyl-1H-imidazole derivatives (2a–c) were synthesized and characterized using IR, 1H NMR and GC–MS spectra. These compounds were in vitro screened against several bacterial species as well as Candida albicans, the common fungi species and found exhibiting moderate to potent activity. Docking of synthesized compounds against glucosamine-6-phosphate synthase, the target enzyme for the antimicrobial agents, was achieved to explore and explain the interactions of the discovered hits within the amino acid residues of the enzyme binding pocket. The docking results enhanced the activity of new derivatives as promising antimicrobial agents

5 June 2024 in Heliyon
Verified
Journal Article
Open access
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
GMGhosoun Lafta Mohsen
Ghosoun Lafta Mohsen
BJBilal Husam Jasim
Bilal Husam Jasim
MJMajid S. Jabir
Majid S. Jabir
ARAbduljabbar I.R. Rushdi
Abduljabbar I.R. Rushdi
Younis BaqiYounis Baqi
Younis Baqi
New 3-furan-1-thiophene-based chalcones were synthesized, characterized and pharmacologically evaluated as antibacterial and anticancer agents against two bacterial species; Gram-positive (Streptococcus pyogenes) and Gram-negative (Pseudomonas aeruginosa). All tested final compounds were active against the two bacterial species; S. pyogenes and P . aeruginosa. Especially compound AM4 showed large inhibition zone (27.13 and 23.30 mm), respectively. Using the DPPH assay, the new chalcones were evaluated for their free radical scavenging activity and found to reach up to 90 %, accomplished at a test concentration of 200 μg/mL. Furthermore, the chalcone derivatives were investigated against two breast cell lines; MCF-7 (cancerous) and MCF-10A (non-cancerous). Compound AM4 showed potent anticancer activity (IC50 = 19.354 μg/mL) in comparison to the other tested chalcone derivatives. In silico study was achieved using the PyRx AutoDock Vina software (0.8) to study the interaction types between the new hits and the binding sites of targeted proteins; glucosamine-6-phosphate synthase and tubulin, the target for antibacterial and anticancer drugs, respectively. Based on the molecular docking results the tested chalcones bind to the active pocket of the respective proteins, which support the in vitro results. In conclusion, 3-furan-1-thiophene-based chalcones could serve as new hits in the discovery of novel anticancer and/or antibacterial drugs.

24 May 2021 in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
AIAhmed Hussein Ismail
Ahmed Hussein Ismail
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
ITIvan H.R. Tomi
Ivan H.R. Tomi
AAAli Hussein R. Al-Daraji
Ali Hussein R. Al-Daraji
Younis BaqiYounis Baqi
Younis Baqi
Background: The frequent use of antibacterial agents leads to antimicrobial resistance, which is one of the biggest threats to global health today. Therefore, the discovery of novel antimicrobial agents is still urgently needed to overcome the severe infections caused by these putative pathogens resistant to currently available drugs. Objective: The present work was aimed to synthesize and investigate the preliminary structureactivity relationships (SARs) of isoxazoline and pyrazoline derivatives as antimicrobial agent. Methods: Target compounds were obtained in a multistep reaction synthesis and the antimicrobial activity was investigated in several species; two-gram negative (Escherichia coli and Pseudomonas aeruginosa), two-gram positive (Staphylococcus aureus and Bacillus subtilis) and one fungi (Candida albicans), using cup-plate agar diffusion method. The most potent compounds were docked into glucosamine-6-phosphate synthase (GlcN-6-P), the molecular target enzyme for antimicrobial agents, using Autodock 4.2 program. Results: Herein, thirteen novel target compounds were synthesized in moderate to good isolated yield. Based on the SARs, two compounds (2c and 5c) were found to be potent antimicrobial agents on all tested targets, recording potency higher than amoxicillin, the standard antimicrobial drug. Compound 2b identified as selective for gram-negative, while compound 7a found to be selective for gram-positive. The hit compounds (2c, 5a, 5c and 5d) were subjected to a docking study on glucosamine-6-phosphate synthase (GlcN-6-P). All hits were found to bind to the orthosteric (active) site of the enzyme, which might represent a competitive mechanism of inhibition. Conclusion: The newly synthesized heterocyclic compounds could serve as potent leads for the development of novel antimicrobial agents.

1 January 2024 in Nanotechnology Reviews
Verified
Journal Article
Open access
PDF file
HKHussam H. Kadhum
Hussam H. Kadhum
SISumayah Ibraheem
Sumayah Ibraheem
ZJZainab Nizar Jawad
Zainab Nizar Jawad
ZJZuhair Mohammed Ali Jeddoa
Zuhair Mohammed Ali Jeddoa
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
Ayman Abdel Aziz SwelumAyman Abdel Aziz Swelum
Ayman Abdel Aziz Swelum
The use of plant extracts as potent reducing agents for the environmentally friendly production of nanoparticles (NPs) has recently attracted the interest of scientists. NPs have received high attention because of their novel properties. The aim of the present study is to biosynthesize zinc oxide nanoparticles (ZnO NPs) using Raphanus sativus and study their effect as antibacterial, anticancer, antiviral, and antidiabetic, agents, NLRP3 inflammasome inhibitors, and inducers of phagocytosis and autophagy. The antibacterial, anticancer, and antiviral activities of ZnO NPs were investigated using different assays: well diffusion assay, MTT assay, reverse transcription polymerase chain reaction, reactive oxygen species generation, and apoptosis assay. Meanwhile, immunofluorescent assay, enzyme-linked immunosorbent assay, and flow cytometry were used for detection of autophagy and phagocytosis. Docking was also achieved to study their binding mode as well as affinity within the target enzymes (glucosamine-6-phosphate synthase) (PDB:1MOQ) active site, estrogen receptor (PDB:3ERT) active site, and tubulin receptor (PDB:4O2B) active site. The results demonstrated that the ZnO NPs have an inhibitory role against bacteria and the proliferation of lung cancer cells (A549). IC 50 was 22.78 µg/mL for A549 cells. For MCF-10, was 272.24 µg/mL, antiviral activity against influenza virus, and antidiabetic agent. Conversely, the results showed the ability of ZnO NPs to reduce inflammasome activity via induction of autophagy. The study’s findings show that R. sativus can be easily and effectively used to synthesize ZnO NPs, and they also highlight the ZnO NPs’ considerable potential as antibacterial, antiviral, anticancer, NLRP3 inflammasome inhibitor, antidiabetic agent, and phagocytosis and autophagy inducer. Based on our findings, the green synthesized ZnO NPs could be used as promising therapeutic agents for biomedical applications.

20 August 2010 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
RKReema Abu Khalaf
Reema Abu Khalaf
MMMohammad S. Mubarak
Mohammad S. Mubarak
Mutasem TahaMutasem Taha
Mutasem Taha

24 December 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
IMInas S. Mahdi
Inas S. Mahdi
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
AJAbdulkadir Mohammed Noori Jassim
Abdulkadir Mohammed Noori Jassim
Younis BaqiYounis Baqi
Younis Baqi
The present work focuses on the synthesis and preliminary structure activity relationships (SARs) of furan-derived chalcones and their corresponding ∆2-pyrazoline derivatives as antimicrobial agents. Eight novel chalcone derivatives and eight ∆2-pyrazoline compounds were synthesized in moderate to good isolated yields. The target compounds were evaluated as antimicrobial agents against two Gram-positive (Staphylococcus aureus and Staphylococcus epidermidis), two Gram-negative (Escherichia coli and Klebsiella pneumoniae), and fungi (Candida albicans) species. Based on the SARs, chalcones 2a and 2h showed inhibition activity on all tested microbial species, while ∆2-pyrazoline 3d was found to be selective for some microbial species. The most potent compounds (2a, 2h, and 3d) were docked into glucosamine-6-phosphate synthase (GlcN-6-P), the molecular target enzyme for antimicrobial agents, utilizing the Autodock 4.2 program, in order to study their virtual affinity and binding mode with the target enzyme. The selected potent compounds were found to bind to the active site of the enzyme probably in a similar way to that of the substrate as suggested by the docking study. In summary, the newly developed furan-derived chalcones and their ∆2-pyrazoline derivatives could serve as potent leads toward the development of novel antimicrobial agents.